Zkusit zdarma
Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

PSTX
Cena:
 
 
Valuace
70
Růst
55
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

9:24 20-12-2024

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t...

Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run?

Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run?

10:15 13-12-2024

Poseida Therapeutics (PSTX) is at a 52-week high, but can investors hope for more gains in the futur...

Should You Buy Poseida Therapeutics, Inc. (PSTX) After Golden Cross?

Should You Buy Poseida Therapeutics, Inc. (PSTX) After Golden Cross?

10:56 28-11-2024

From a technical perspective, Poseida Therapeutics, Inc. (PSTX) is looking like an interesting pick,...

Wall Street Analysts Think Poseida Therapeutics (PSTX) Could Surge 49.25%: Read This Before Placing a Bet

Wall Street Analysts Think Poseida Therapeutics (PSTX) Could Surge 49.25%: Read This Before Placing a Bet

11:00 27-11-2024

The consensus price target hints at a 49.3% upside potential for Poseida Therapeutics (PSTX). While ...

Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue?

Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue?

10:16 27-11-2024

Poseida Therapeutics (PSTX) is at a 52-week high, but can investors hope for more gains in the futur...

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Poseida Therapeutics, Inc. - PSTX

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Poseida Therapeutics, Inc. - PSTX

20:50 26-11-2024

NEW YORK , Nov. 26, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), h...

Why This Gene-Therapy Company's Stock Is Rising 228%

Why This Gene-Therapy Company's Stock Is Rising 228%

11:10 26-11-2024

Poseida Therapeutics, a cell therapy company, is being acquired by Roche in a $1.5 billion deal....

Shareholder Alert: Ademi LLP investigates whether Poseida Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Poseida Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

9:22 26-11-2024

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Poseida (Nasdaq: PSTX) for possible breaches ...

PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

7:23 26-11-2024

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t...

Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% in One Week: What You Should Know

Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% in One Week: What You Should Know

13:05 12-11-2024

Does Poseida Therapeutics, Inc. (PSTX) have what it takes to be a top stock pick for momentum invest...

Poseida Therapeutics to Present at Two Upcoming Investor Conferences

Poseida Therapeutics to Present at Two Upcoming Investor Conferences

16:05 11-11-2024

SAN DIEGO , Nov. 11, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stag...

Poseida Therapeutics, Inc. (PSTX) Q3 Earnings and Revenues Beat Estimates

Poseida Therapeutics, Inc. (PSTX) Q3 Earnings and Revenues Beat Estimates

18:56 07-11-2024

Poseida Therapeutics, Inc. (PSTX) came out with quarterly earnings of $0.21 per share, beating the Z...

Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024

Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024

16:05 07-11-2024

Strong collaboration momentum with Roche expansion of CAR-T partnership and Astellas nomination of ...

Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema

Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema

8:00 24-10-2024

Data to be highlighted in a Distinguished Industry Oral Abstract presentation at the American Colleg...

Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024

Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024

16:30 03-10-2024

Inclusion on list recognizes Poseida for employee sentiment and satisfaction SAN DIEGO , Oct. 3, 20...

Poseida Therapeutics: An Underappreciated Company Continuing To Shape Up Well In 2024

Poseida Therapeutics: An Underappreciated Company Continuing To Shape Up Well In 2024

9:16 09-09-2024

Poseida Therapeutics shows promising early results in myeloma with their BCMA-directed allogeneic CA...

Poseida Therapeutics to Present at Upcoming Investor Conferences

Poseida Therapeutics to Present at Upcoming Investor Conferences

16:05 29-08-2024

SAN DIEGO , Aug. 29, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stag...

Poseida Therapeutics, Inc. (PSTX) Reports Q2 Loss, Tops Revenue Estimates

Poseida Therapeutics, Inc. (PSTX) Reports Q2 Loss, Tops Revenue Estimates

18:55 05-08-2024

Poseida Therapeutics, Inc. (PSTX) came out with a quarterly loss of $0.32 per share versus the Zacks...

Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024

Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024

16:05 05-08-2024

Continued Roche CAR-T partnership progress with agreement for Poseida to initiate Phase 1b portion o...

Are You Looking for a Top Momentum Pick? Why Poseida Therapeutics, Inc. (PSTX) is a Great Choice

Are You Looking for a Top Momentum Pick? Why Poseida Therapeutics, Inc. (PSTX) is a Great Choice

13:01 19-07-2024

Does Poseida Therapeutics, Inc. (PSTX) have what it takes to be a top stock pick for momentum invest...

close

IKENA ONCOLOGY AND INMAGENE BIOPHARMACEUTICALS ANNOUNCE KRISTIN YAREMA, PH.D., AS CHIEF EXECUTIVE OFFICER OF MERGED COMPANY

23-07-2025
BOSTON AND SAN DIEGO, JULY 23, 2025 (GLOBE NEWSWIRE) -- IKENA ONCOLOGY, INC. (NASDAQ: IKNA) (“IKEN...
Více zde

PSTX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF POSEIDA THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS

20-12-2024
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

POSEIDA THERAPEUTICS HIGHLIGHTS POSITIVE INTERIM PHASE 1 RESULTS FOR P-BCMA-ALLO1 AND PRECLINICAL DATA FOR DUAL CAR-T P-CD19CD20-ALLO1 AT THE 66TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING

09-12-2024
ADDITIONAL NEW PROFILING OF PATIENT RESPONSES FROM THE OPTIMIZED LYMPHODEPLETION ARM (ARM C) SHOW CO...
Více zde

POSEIDA THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF POSEIDA THERAPEUTICS, INC. - PSTX

27-11-2024
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

SHAREHOLDER ALERT: THE M&A CLASS ACTION FIRM INVESTIGATES THE MERGER OF POSEIDA THERAPEUTICS, INC. - PSTX

26-11-2024
NEW YORK , NOV. 26, 2024 /PRNEWSWIRE/ -- MONTEVERDE & ASSOCIATES PC (THE "M&A CLASS ACTION FIRM"), H...
Více zde

SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER POSEIDA THERAPEUTICS, INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

26-11-2024
MILWAUKEE--(BUSINESS WIRE)--ADEMI LLP IS INVESTIGATING POSEIDA (NASDAQ: PSTX) FOR POSSIBLE BREACHES ...
Více zde

PSTX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF POSEIDA THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS

26-11-2024
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

POSEIDA THERAPEUTICS, INC. ANNOUNCES AGREEMENT TO BE ACQUIRED BY ROCHE HOLDINGS, INC.

26-11-2024
POSEIDA STOCKHOLDERS TO RECEIVE UP TO $13.00 PER SHARE IN CASH, COMPRISED OF $9.00 PER SHARE IN CASH...
Více zde

POSEIDA THERAPEUTICS HOSTS CELL THERAPY R&D DAY HIGHLIGHTING ITS INNOVATIVE CLINICAL AND PRECLINICAL PIPELINE

14-11-2024
EMERGING LEADERSHIP IN ALLOGENEIC CAR-T FOR HEMATOLOGIC MALIGNANCIES DEMONSTRATED BY RECENT P-BCMA-A...
Více zde

POSEIDA THERAPEUTICS TO PRESENT AT TWO UPCOMING INVESTOR CONFERENCES

11-11-2024
SAN DIEGO , NOV. 11, 2024 /PRNEWSWIRE/ -- POSEIDA THERAPEUTICS, INC. (NASDAQ: PSTX), A CLINICAL-STAG...
Více zde

POSEIDA THERAPEUTICS PROVIDES UPDATES AND FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2024

07-11-2024
STRONG COLLABORATION MOMENTUM WITH ROCHE EXPANSION OF CAR-T PARTNERSHIP AND ASTELLAS NOMINATION OF ...
Více zde

POSEIDA THERAPEUTICS TO PRESENT CLINICAL AND PRECLINICAL DATA ON INVESTIGATIONAL ALLOGENEIC CAR-T CELL THERAPIES AT SITC 2024 AND ASH 2024

05-11-2024
NEW PRECLINICAL DATA ON ALLOGENEIC CAR+TCR-T CELLS RICH IN STEM CELL MEMORY T CELLS (TSCM) AND ENHAN...
Více zde

POSEIDA THERAPEUTICS TO PRESENT NEW PRECLINICAL DATA SUPPORTING NON-VIRAL GENE EDITING WITH P-KLKB1-101 FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA

24-10-2024
DATA TO BE HIGHLIGHTED IN A DISTINGUISHED INDUSTRY ORAL ABSTRACT PRESENTATION AT THE AMERICAN COLLEG...
Více zde

POSEIDA THERAPEUTICS ANNOUNCES NOMINATION OF NEW CAR-T DEVELOPMENT CANDIDATE UNDER COLLABORATION WITH ROCHE

17-10-2024
ALLOGENEIC, TSCM-RICH DUAL CAR-T FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES, INCLUDING MULTIPLE M...
Více zde

POSEIDA THERAPEUTICS NAMED TO NEWSWEEK'S LIST OF THE TOP 200 AMERICA'S MOST LOVED WORKPLACES FOR 2024

03-10-2024
INCLUSION ON LIST RECOGNIZES POSEIDA FOR EMPLOYEE SENTIMENT AND SATISFACTION SAN DIEGO , OCT. 3, 20...
Více zde

POSEIDA THERAPEUTICS REPORTS POSITIVE INTERIM PHASE 1 RESULTS FOR ALLOGENEIC CAR-T THERAPY P-BCMA-ALLO1 WITH HIGH OVERALL RESPONSE RATES IN HEAVILY PRETREATED RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS

27-09-2024
DATA SHOWED A 91% ORR WITH P-BCMA-ALLO1 IN AN OPTIMIZED LYMPHODEPLETION ARM, INCLUDING A 100% ORR I...
Více zde

POSEIDA THERAPEUTICS RECEIVES REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FROM FDA FOR P-BCMA-ALLO1 TO TREAT RELAPSED/REFRACTORY MULTIPLE MYELOMA

16-09-2024
FDA EVALUATED RMAT APPLICATION BASED ON POSITIVE CLINICAL DATA FROM ONGOING PHASE 1 STUDY OF P-BCMA-...
Více zde

POSEIDA THERAPEUTICS TO PRESENT NEW CLINICAL DATA FROM PHASE 1 STUDY OF ALLOGENEIC CAR-T P-BCMA-ALLO1 IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AT 21ST INTERNATIONAL MYELOMA SOCIETY ANNUAL MEETING

05-09-2024
LATEST DATA FROM POSEIDA'S LEAD INVESTIGATIONAL ALLOGENEIC CAR-T PROGRAM, WHICH IS BASED ON THE COMP...
Více zde

POSEIDA THERAPEUTICS PRESENTS NEW CASE STUDY DEMONSTRATING REACTIVATION OF CAR-T THERAPY WITH A T-CELL ENGAGER IN A PATIENT WITH RELAPSED MULTIPLE MYELOMA

04-09-2024
REACTIVATION OF P-BCMA-101 CAR-T CELLS AND A REPEAT STRINGENT COMPLETE RESPONSE (SCR) MORE THAN 3 Y...
Více zde

POSEIDA THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

29-08-2024
SAN DIEGO , AUG. 29, 2024 /PRNEWSWIRE/ -- POSEIDA THERAPEUTICS, INC. (NASDAQ: PSTX), A CLINICAL-STAG...
Více zde

POSEIDA THERAPEUTICS PROVIDES UPDATES AND FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2024

05-08-2024
CONTINUED ROCHE CAR-T PARTNERSHIP PROGRESS WITH AGREEMENT FOR POSEIDA TO INITIATE PHASE 1B PORTION O...
Více zde

POSEIDA THERAPEUTICS ANNOUNCES PARTICIPATION IN STIFEL'S 2024 VIRTUAL CELL THERAPY FORUM

01-07-2024
SAN DIEGO , JULY 1, 2024 /PRNEWSWIRE/ -- POSEIDA THERAPEUTICS, INC. (NASDAQ: PSTX), A CLINICAL-STAGE...
Více zde

POSEIDA THERAPEUTICS ANNOUNCES VIRTUAL 2024 ANNUAL MEETING OF STOCKHOLDERS

03-06-2024
SAN DIEGO , JUNE 3, 2024 /PRNEWSWIRE/ -- POSEIDA THERAPEUTICS, INC. (NASDAQ: PSTX), A CLINICAL-STAG...
Více zde

POSEIDA THERAPEUTICS PROVIDES UPDATES AND FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2024

14-05-2024
EXPANDED STRATEGIC RELATIONSHIP WITH ASTELLAS WITH NEW RESEARCH COLLABORATION LEVERAGING POSEIDA'S ...
Více zde

POSEIDA HIGHLIGHTS STRONG PROGRESS ON ITS GENETIC MEDICINE PROGRAMS AT THE AMERICAN SOCIETY FOR GENE AND CELL THERAPY 27TH ANNUAL MEETING

09-05-2024
EARLY NON-HUMAN PRIMATE (NHP) DATA FOR P-KLKB1-101 DEMONSTRATE SUCCESSFUL LIVER GENE EDITING APPROAC...
Více zde

ASTELLAS AND POSEIDA THERAPEUTICS ENTER INTO RESEARCH COLLABORATION AND LICENSE AGREEMENT TO DEVELOP NOVEL ALLOGENEIC CELL THERAPIES IN ONCOLOGY

01-05-2024
- LEVERAGES POSEIDA'S PROPRIETARY ALLOGENEIC CAR-T PLATFORM TO DEVELOP INNOVATIVE CONVERTIBLECAR® P...
Více zde

POSEIDA THERAPEUTICS ANNOUNCES STRONG LINEUP OF PRESENTATIONS AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY 27TH ANNUAL MEETING

18-04-2024
COMPANY TO DELIVER THREE ORAL AND THREE POSTER PRESENTATIONS HIGHLIGHTING ITS PORTFOLIO OF NON-VIRAL...
Více zde

POSEIDA THERAPEUTICS HOSTS GENE THERAPY R&D DAY HIGHLIGHTING NEW SCIENTIFIC ADVANCEMENTS AND PIPELINE FOCUS

17-04-2024
FULLY NON-VIRAL APPROACH TO GENETIC MEDICINE EMPLOYS DIFFERENTIATED GENE DELIVERY, GENE EDITING AND ...
Více zde

POSEIDA THERAPEUTICS PRESENTS NEW PHASE 1 DATA AT AACR 2024 SUPPORTING POTENTIAL OF P-BCMA-ALLO1 ALLOGENEIC CAR-T THERAPY TO BENEFIT BROAD RANGE OF PATIENTS WITH MULTIPLE MYELOMA

08-04-2024
PROMISING EARLY DATA SUGGEST PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO PROGRESSED AFTE...
Více zde

POSEIDA THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

01-04-2024
SAN DIEGO , APRIL 1, 2024 /PRNEWSWIRE/ -- POSEIDA THERAPEUTICS, INC. (NASDAQ: PSTX), A CLINICAL-STA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-01-08 00:00:008-KStáhnout
2025-01-07 23:00:008-KStáhnout
2024-11-26 00:00:008-KStáhnout
2024-11-25 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-09-30 01:00:008-KStáhnout
2024-09-30 00:00:008-KStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 01:00:0010-QStáhnout
2024-08-05 00:00:008-KStáhnout
2024-08-05 00:00:0010-QStáhnout
2024-06-18 01:00:008-KStáhnout
2024-06-18 00:00:008-KStáhnout
2024-05-14 01:00:008-KStáhnout
2024-05-14 01:00:0010-QStáhnout
2024-05-14 00:00:008-KStáhnout
2024-05-14 00:00:0010-QStáhnout
2024-05-01 01:00:008-KStáhnout
2024-05-01 00:00:008-KStáhnout
2024-04-17 01:00:008-KStáhnout
2024-04-17 00:00:008-KStáhnout
2024-04-08 01:00:008-KStáhnout
2024-04-08 00:00:008-KStáhnout
2024-03-07 00:00:008-KStáhnout
2024-03-07 00:00:0010-KStáhnout
2024-03-06 23:00:008-KStáhnout
2024-03-06 23:00:0010-KStáhnout
2024-01-04 00:00:008-KStáhnout
2024-01-03 23:00:008-KStáhnout
2023-12-11 00:00:008-KStáhnout
2023-12-10 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-10-10 01:00:008-KStáhnout
2023-10-10 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 00:00:008-KStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-06-01 01:00:008-KStáhnout
2023-06-01 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-04-13 01:00:008-KStáhnout
2023-04-13 00:00:008-KStáhnout
2023-03-30 01:00:008-KStáhnout
2023-03-30 00:00:008-KStáhnout
2023-03-09 00:00:008-KStáhnout
2023-03-09 00:00:0010-KStáhnout
2023-03-08 23:00:008-KStáhnout
2023-03-08 23:00:0010-KStáhnout
2023-02-22 00:00:008-KStáhnout
2023-02-21 23:00:008-KStáhnout
2023-01-31 00:00:008-KStáhnout
2023-01-30 23:00:008-KStáhnout
2022-12-06 00:00:008-KStáhnout
2022-12-05 23:00:008-KStáhnout
2022-12-01 00:00:008-KStáhnout
2022-11-30 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-09-07 01:00:008-KStáhnout
2022-09-07 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-05-18 01:00:008-KStáhnout
2022-05-18 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-04-07 01:00:008-KStáhnout
2022-04-07 00:00:008-KStáhnout
2022-03-10 00:00:008-KStáhnout
2022-03-10 00:00:0010-KStáhnout
2022-03-09 23:00:008-KStáhnout
2022-03-09 23:00:0010-KStáhnout
2022-02-23 00:00:008-KStáhnout
2022-02-22 23:00:008-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-02-17 00:00:008-KStáhnout
2022-02-16 23:00:008-KStáhnout
2022-02-01 00:00:008-KStáhnout
2022-01-31 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-10-13 01:00:008-KStáhnout
2021-10-13 00:00:008-KStáhnout
2021-10-12 01:00:008-KStáhnout
2021-10-12 00:00:008-KStáhnout
2021-08-31 01:00:008-KStáhnout
2021-08-31 00:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-07-26 01:00:008-KStáhnout
2021-07-26 00:00:008-KStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-05-11 01:00:008-KStáhnout
2021-05-11 01:00:0010-QStáhnout
2021-05-11 00:00:008-KStáhnout
2021-05-11 00:00:0010-QStáhnout
2021-03-11 00:00:008-KStáhnout
2021-03-11 00:00:0010-KStáhnout
2021-03-10 23:00:008-KStáhnout
2021-03-10 23:00:0010-KStáhnout
2021-02-24 00:00:008-KStáhnout
2021-02-23 23:00:008-KStáhnout
2021-02-23 00:00:008-KStáhnout
2021-02-22 23:00:008-KStáhnout
2020-12-17 00:00:008-KStáhnout
2020-12-16 23:00:008-KStáhnout
2020-12-07 00:00:008-KStáhnout
2020-12-06 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-11-02 00:00:008-KStáhnout
2020-11-01 23:00:008-KStáhnout
2020-09-16 01:00:008-KStáhnout
2020-09-16 00:00:008-KStáhnout
2020-08-20 01:00:008-KStáhnout
2020-08-20 01:00:0010-QStáhnout
2020-08-20 00:00:008-KStáhnout
2020-08-20 00:00:0010-QStáhnout
2020-08-17 01:00:008-KStáhnout
2020-08-17 00:00:008-KStáhnout
2020-07-14 01:00:008-KStáhnout
2020-07-14 00:00:008-KStáhnout
preloader